Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The burden of hematological malignancies in Latin America and the Caribbean: A 30-year global burden of disease analysis

Héctor Alejandro Vaquera Alfaro, Alejandra De Las Fuentes, Andres Noyola-Perez, José Emiliano Montelongo-Cepeda, Sofia Isabel Quezada Ramirez, Andres Gomez-De Leon, Edward Christopher Dee, Julia Esther Colunga-Pedraza, Michelle Morcos, Alexia E. Gonzalez-Lozano, Rubi Alejandra Orta-Martinez, Olga Cantu, David Gomez-Almaguer, Luis Malpica, James Wu, Perla R. Colunga-Pedraza

Blood (2025) 146 (Supplement 1): 4615.

https://doi.org/10.1182/blood-2025-4615

Published: 2025

Journal Articles

Geriatric hematologic care in Latin America: Results from a regional survey of hematology centers

Blood (2025) 146 (Supplement 1): 4417.

https://doi.org/10.1182/blood-2025-4417

Published: 2025

Journal Articles

Pre-transplant nutritional status and hospitalization risk in outpatient hematopoietic stem cell transplantation: A prospective study using the patient-generated subjective global assessment

Alexia E. Gonzalez-Lozano, Michelle Morcos, Héctor Alejandro Vaquera Alfaro, Anahí Morales Pedraza, Anel Melissa de la Torre Salinas, César Gutierrez-Aguirre, Marisa Frausto, Francisco Buendia-Pelaez, Jorge Montemayor, Luis Gonzalez, Paulo Ugarte-Peláez, Francisco Rubio, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2025) 146 (Supplement 1): 4285.

https://doi.org/10.1182/blood-2025-4285

Published: 2025

Journal Articles

Access to diagnostics, therapies, and advanced care for lymphoma in Latin America: A multicenter, survey-based study

Blood (2025) 146 (Supplement 1): 6193.

https://doi.org/10.1182/blood-2025-6193

Published: 2025

Journal Articles

National health systems characteristics and lymphoma outcomes: A global analysis

Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, David Gomez-Almaguer, Erin Feliciano, Edward Christopher Dee, James Wu

Blood (2025) 146 (Supplement 1): 6267.

https://doi.org/10.1182/blood-2025-6267

Published: 2025

Journal Articles

Breaking geographic barriers in a Mexican ambulatory transplant program: Early outcomes in a diverse national and international cohort

Yadith Karina Lopez-Garcia, Alejandra De Las Fuentes, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Michelle Morcos, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Luz Tarin, Olga Cantu, César Gutierrez-Aguirre, David Gomez-Almaguer

Blood (2025) 146 (Supplement 1): 722.

https://doi.org/10.1182/blood-2025-722

Published: 2025

Journal Articles

Measuring success by different rulers: Heterogeneity in definition of outcomes in immune thrombocytopenia trials

Sofia Isabel Quezada Ramirez, Héctor Alejandro Vaquera Alfaro, José Emiliano Montelongo-Cepeda, Alejandra De Las Fuentes, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2025) 146 (Supplement 1): 3038.

https://doi.org/10.1182/blood-2025-3038

Published: 2025

Journal Articles

Revisiting accessible therapies for the management of Myelodysplastic Syndromes: A retrospective analysis of danazole, nandrolone or both.

Alejandra De Las Fuentes, Jorge Montemayor, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Yadith Karina Lopez-Garcia, Marisa Fraustro, Luis Gonzalez, Francisco Buendia-Pelaez, Andres Gomez-De Leon, Luz Tarin, César Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2025) 146 (Supplement 1): 7371.

https://doi.org/10.1182/blood-2025-7371

Published: 2025

Journal Articles

Bioinformatic Evaluation of Molecular Differences in HLA-B and Their Effect on Graft-Versus-Host Disease in Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation from Related Donors

Michelle Morcos, Alexia Gonzalez, Héctor Alejandro Vaquera Alfaro, Dalila Marisol Alvarado-Navarro, Perla R. Rocio Colunga-Pedraza, Andres Gomez-De Leon, Rosario Salazar-Riojas, Maria Luisa Aguilar-Escobedo, Luis Paulo Ugarte Pelaez, Francisco Javier Rubio Macias, Olga Cantu, David Gomez-Almaguer, Nidia Karina Moncada Saucedo

Blood (2024) 144 (Supplement 1): 7514.

https://doi.org/10.1182/blood-2024-208823

Published: 2024

Journal Articles

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Yadith Karina Lopez-Garcia, Sara Redondo Velao, Andres Gomez-De Leon, Irene García-Cadenas, Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Albert Esquirol, César Homero Gutierrez-Aguirre, José Carlos Jaime-Pérez, Jorge Sierra, Olga Cantu, Javier Briones, David Gomez-Almaguer, Rodrigo Martino

Blood (2024) 144 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2024-210332

Published: 2024

Journal Articles

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Alejandra De las Fuentes-Cepeda, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Michelle Morcos, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Antonio Vega Mateos, César Homero Gutierrez-Aguirre, Olga Cantu, Luz Tarin-Arzaga, Consuelo Mancías-Guerra, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles

Blood (2024) 144 (Supplement 1): 7299.

https://doi.org/10.1182/blood-2024-210921

Published: 2024

Journal Articles

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Antonio Vega Mateos, Héctor Alejandro Vaquera Alfaro, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Olga Cantu, Andres Gomez-De Leon, David Gomez-Almaguer, Luz Tarin-Arzaga, César Homero Gutierrez-Aguirre, Perla R. Colunga-Pedraza

Blood (2024) 144 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2024-208831

Published: 2024

Journal Articles

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Héctor Alejandro Vaquera Alfaro, Zulia Guzman-Martínez, Antonio Vega-Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, César Homero Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 1711.

https://doi.org/10.1182/blood-2023-188171

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

The burden of hematological malignancies in Latin America and the Caribbean: A 30-year global burden of disease analysis

Geriatric hematologic care in Latin America: Results from a regional survey of hematology centers

Pre-transplant nutritional status and hospitalization risk in outpatient hematopoietic stem cell transplantation: A prospective study using the patient-generated subjective global assessment

Access to diagnostics, therapies, and advanced care for lymphoma in Latin America: A multicenter, survey-based study

National health systems characteristics and lymphoma outcomes: A global analysis

Breaking geographic barriers in a Mexican ambulatory transplant program: Early outcomes in a diverse national and international cohort

Measuring success by different rulers: Heterogeneity in definition of outcomes in immune thrombocytopenia trials

Revisiting accessible therapies for the management of Myelodysplastic Syndromes: A retrospective analysis of danazole, nandrolone or both.

Bioinformatic Evaluation of Molecular Differences in HLA-B and Their Effect on Graft-Versus-Host Disease in Patients Receiving Haploidentical Hematopoietic Stem Cell Transplantation from Related Donors

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only